Objective: The aim of this study was to compare the antihypertensive efficacy and tolerability of the calcium channel antagonist amlodipine besylate versus the angiotensin II type 1 receptor ...

Amlodipine oral tablet contains the active drug amlodipine besylate. It’s classified as a calcium channel blocker. If you have certain heart conditions, your doctor may prescribe amlodipine oral ...

Nov. 11, 2005 — The U.S. Food and Drug Administration (FDA) has approved first-time generic formulations of glimepiride 1-, 2-, and 4-mg tablets and first-time doses of 3-, 6-, and 8-mg tablets for ...

Amlodipine commonly causes swelling in the legs and ankles, along with other mild effects like headache, fatigue, and stomach pain that are usually temporary and manageable. Serious side effects can ...

On Thursday, Pharma giant Pfizer said it will appeal the Canadian Federal Court's decision to declare invalid a patent covering amlodipine besylate--the active ingredient in its hypertension drug ...

Unichem laboratories Limited are pleased to announce that it has received ANDA approval from the United States Food and Drug Administration (US FDA) for Amlodipine Besylate Tablets. Amlodipine ...

Having lost a patent case over its blockbuster blood pressure drug Norvasc, Pfizer has begun selling a generic version of its own medicine just as Mylan Laboratories launched its copycat of the ...

Pfizer Inc.’s patent on the hypertension drug Norvasc was invalidated by an appeals court Thursday, opening the way for generic competition to the company’s second-biggest seller. The U.S. Court of ...